Literature DB >> 27573491

Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities.

Johan Høy Jensen1, Ulla Knorr2, Maj Vinberg3, Lars V Kessing4, Kamilla W Miskowiak5.   

Abstract

BACKGROUND: Neurocognitive impairment in remitted patients with bipolar disorder contributes to functional disabilities. However, the pattern and impact of these deficits are unclear.
METHODS: We pooled data from 193 fully or partially remitted patients with bipolar disorder and 110 healthy controls. Hierarchical cluster analysis was conducted to determine whether there are discrete neurocognitive subgroups in bipolar disorder. The pattern of the cognitive deficits and the characteristics of patients in these neurocognitive subgroups were examined with analyses of covariance and least significance difference pairwise comparison.
RESULTS: Three discrete neurocognitive subgroups were detected: one that was cognitively intact (46.1%), one that was selectively impaired with deficits in processing speed (32.6%), and one that was globally impaired across verbal learning, working memory, and executive skills (21.2%). The globally and selectively impaired subgroups were characterized by greater perceived stress and subjective cognitive complaints, poorer work and social adjustment, and reduced quality of life compared to patients who were cognitively intact. LIMITATIONS: The study design was cross-sectional which limits inferences regarding the causality of the findings.
CONCLUSION: Globally and selectively impaired bipolar disorder patients displayed more functional disabilities than those who were cognitively intact. The present findings highlight a clinical need to systematically screen for cognitive dysfunction in remitted bipolar disorder and to target residual cognitive dysfunction in future treatment strategies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27573491     DOI: 10.1016/j.jad.2016.08.018

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  18 in total

Review 1.  Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment.

Authors:  Ni Xu; Benjamin Huggon; Kate E A Saunders
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

2.  Impact of pretreatment interhemispheric hippocampal asymmetry on improvement in verbal learning following erythropoietin treatment in mood disorders: a randomized controlled trial

Authors:  Kamilla W. Miskowiak; Julie L. Forman; Maj Vinberg; Hartwig R. Siebner; Lars V. Kessing; Julian Macoveanu
Journal:  J Psychiatry Neurosci       Date:  2020-05-01       Impact factor: 6.186

3.  Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings.

Authors:  M Russo; T E Van Rheenen; M Shanahan; K Mahon; M M Perez-Rodriguez; A Cuesta-Diaz; E Larsen; A K Malhotra; K E Burdick
Journal:  Psychol Med       Date:  2017-06-07       Impact factor: 7.723

4.  Person-based similarity in brain structure and functional connectivity in bipolar disorder.

Authors:  Gaelle E Doucet; David C Glahn; Sophia Frangou
Journal:  J Affect Disord       Date:  2020-07-13       Impact factor: 4.839

5.  Heterogeneity of social cognitive and language functions in children at familial high-risk of severe mental illness; The Danish High Risk and Resilience Study VIA 7.

Authors:  Merete Nordentoft; Jens Richardt Møllegaard Jepsen; Camilla Jerlang Christiani; Nicoline Hemager; Ditte Ellersgaard; Anne A E Thorup; Katrine Søborg Spang; Birgitte Klee Burton; Maja Gregersen; Anne Søndergaard; Aja Greve; Ditte Lou Gantriis; Ole Mors; Kerstin J Plessen
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-02-09       Impact factor: 4.785

Review 6.  Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.

Authors:  Brisa Solé; Esther Jiménez; Carla Torrent; Maria Reinares; Caterina Del Mar Bonnin; Imma Torres; Cristina Varo; Iria Grande; Elia Valls; Estela Salagre; Jose Sanchez-Moreno; Anabel Martinez-Aran; André F Carvalho; Eduard Vieta
Journal:  Int J Neuropsychopharmacol       Date:  2017-08-01       Impact factor: 5.176

7.  Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.

Authors:  Jeff Zarp Petersen; Lejla Sjanic Schmidt; Maj Vinberg; Martin Balslev Jørgensen; Ida Hageman; Hannelore Ehrenreich; Gitte Moos Knudsen; Lars Vedel Kessing; Kamilla Woznica Miskowiak
Journal:  Trials       Date:  2018-11-06       Impact factor: 2.279

8.  Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force.

Authors:  K W Miskowiak; K E Burdick; A Martinez-Aran; C M Bonnin; C R Bowie; A F Carvalho; P Gallagher; B Lafer; C López-Jaramillo; T Sumiyoshi; R S McIntyre; A Schaffer; R J Porter; I J Torres; L N Yatham; A H Young; L V Kessing; E Vieta
Journal:  Bipolar Disord       Date:  2017-09-12       Impact factor: 6.744

9.  Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.

Authors:  Caroline V Ott; Maj Vinberg; Christopher R Bowie; Ellen Margrethe Christensen; Gitte M Knudsen; Lars V Kessing; Kamilla W Miskowiak
Journal:  Trials       Date:  2018-09-12       Impact factor: 2.279

10.  Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?-A Perspective Paper.

Authors:  Lars Vedel Kessing; Kamilla Miskowiak
Journal:  Front Psychiatry       Date:  2018-10-08       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.